Thomas Milz
Corporate Officer/Principal chez APONTIS PHARMA AG
Postes actifs de Thomas Milz
Sociétés | Poste | Début | Fin |
---|---|---|---|
APONTIS PHARMA AG | Corporate Officer/Principal | 01/01/2021 | - |
PP Apontis Pharma GmbH
PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019. | Directeur Général | 01/05/2021 | - |
Historique de carrière de Thomas Milz
Anciens postes connus de Thomas Milz
Sociétés | Poste | Début | Fin |
---|---|---|---|
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/2017 | 01/01/2018 |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/2007 | 01/01/2016 |
Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | 01/01/1997 | 01/01/1999 |
Sales & Marketing | 01/01/1999 | 01/01/2007 | |
Sanol GmbH | Sales & Marketing | 01/01/1999 | 01/01/2007 |
Madaus AG | Corporate Officer/Principal | 01/01/1996 | 01/01/1997 |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | 01/01/1993 | 01/01/1996 |
Formation de Thomas Milz
Fachhochschule Düsseldorf | Undergraduate Degree |
Statistiques
Internationale
Allemagne | 9 |
Opérationnelle
Corporate Officer/Principal | 6 |
Sales & Marketing | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
APONTIS PHARMA AG | Health Technology |
Entreprise privées | 6 |
---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Schwarz Pharma Deutschland GmbH | |
PP Apontis Pharma GmbH
PP Apontis Pharma GmbH Financial ConglomeratesFinance PP Apontis Pharma GmbH is an investment holding German company. The company is based in Monheim am Rhein, Germany. The CEOs are Thomas Milz and Thomas Zimmermann. The private company was founded in 2019. | Finance |
Apontis Pharma GmbH & Co. KG
Apontis Pharma GmbH & Co. KG Pharmaceuticals: MajorHealth Technology APONTIS PHARMA Deutschland GmbH & Co. KG engages in the wholesale of pharmaceutical products. It focuses on medicines used for the treatment of chronic obstructive pulmonary diseases, hypertension, and cardiovascular diseases. The company was founded on February 13, 2015 and is headquartered in Monheim, Germany. | Health Technology |
Sanol GmbH | |
Madaus AG |
- Bourse
- Insiders
- Thomas Milz
- Expérience